Having trouble accessing articles? Reset your cache.

Agennix planning rights issue

Agennix AG (Xetra:AGX) plans to raise up to EUR 78.4 million ($100.5 million) through the sale of

Read the full 175 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE